[A gene involved in angiogenesis and bone -osteopontin]
Masaki Noda1, Kunikazu Tsuji, Mikihiko Morinobu
1Department of Molecular Pharmacology Medical Research Institute, Tokyo Medical and Dental University.
Summary
Osteopontin promotes endothelial cell survival and blood vessel growth in bone. Further research into bone angiogenesis mechanisms is crucial for understanding metabolic bone diseases like osteoporosis.
Area of Science:
- Molecular Biology
- Bone Physiology
- Vascular Biology
Context:
- Osteopontin is a key protein found in bone and hard tissues.
- Bone remodeling is critical in metabolic bone diseases, involving complex bone-vascular interactions.
- Understanding angiogenesis in bone is essential for therapeutic development.
Purpose:
- To investigate the role of osteopontin in promoting endothelial cell survival.
- To explore osteopontin's function in enhancing angiogenesis within bone tissue.
- To elucidate molecular mechanisms underlying angiogenesis in the bone microenvironment.
Summary:
- Osteopontin expression in bone supports endothelial cell survival.
- Ectopic implantation experiments demonstrate osteopontin's capacity to enhance bone angiogenesis.
- These findings highlight osteopontin's potential role in the vascularization of bone.
Impact:
- Provides insights into molecular mechanisms regulating bone vascularization.
- Suggests osteopontin as a potential target for therapies related to bone diseases.
- Emphasizes the importance of bone-vessel interactions in osteoporosis and metabolic bone disorders.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Mechanism of Angiogenesis
6.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K
Bone Formation by Endochondral Ossification
7.3K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
7.3K
Canonical Wnt Signaling Pathway
9.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.6K
TGF - β Signaling Pathway
8.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.3K
Osteoclasts in Bone Remodeling
3.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K


